Loading clinical trials...
Loading clinical trials...
The main objective is to identify specific risk factors for ANCA vasculitis of occupational and/or environmental origin (exposures identified by questioning, geographical distribution of cases) from the RNV3P data. The secondary objectives are as follows: * Description of cases of ANCA vasculitis seen in French occupational pathology consultation centres: * reasons for consultation, * occupational and environmental etiologies described * occupational situations responsible * aptitude notices * recognition as an occupational disease * Identification of specific risk factors for ANCA vasculitis of occupational and/or environmental origin (exposures identified on questioning, geographical distribution of cases). * For occupational and non-occupational cases of ANCA vasculitis: identification of difficulties encountered by patients at work and proposed work adaptations. * Estimation of the number of applications for recognition of disabled worker status made within this patient group. * Identification of clinical severity and autoimmune profiles of ANCA vasculitis of occupational and/or environmental origin.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU de Bordeaux
Bordeaux, France
CHU de Grenoble
Grenoble, France
CHU de LILLE
Lille, France
HCL
Lyon, France
AP-HM
Marseille, France
CHU de Nancy
Nancy, France
CHU de Nantes
Nantes, France
Hôpital Cochin ( AP-HP)
Paris, France
CHU de Rennes
Rennes, France
CHU de Strasbourg
Strasbourg, France
Start Date
July 1, 2022
Primary Completion Date
July 1, 2022
Completion Date
August 1, 2022
Last Updated
June 13, 2022
302
ESTIMATED participants
Lead Sponsor
University Hospital, Brest
NCT07417527
NCT07339540
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions